Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS
Holding SYRS?
Track your performance easily

Syros Pharmaceuticals (SYRS) Technical Analysis

916 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Syros Pharmaceuticals’s (SYRS) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Syros Pharmaceuticals is a Sell.
Syros Pharmaceuticals’s (SYRS) 20-Day exponential moving average is 1.98, while Syros Pharmaceuticals’s (SYRS) share price is $2, making it a Buy.
Syros Pharmaceuticals’s (SYRS) 50-Day exponential moving average is 2.80, while Syros Pharmaceuticals’s (SYRS) share price is $2, making it a Sell.

Syros Pharmaceuticals (SYRS) Pivot Points

Nov 10, 2024, 01:41 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.78
1.82
1.89
1.93
2.00
2.04
2.11
Fibonacci
1.82
1.86
1.89
1.93
1.97
2.00
2.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Syros Pharmaceuticals (SYRS) Moving Averages

Nov 10, 2024, 01:41 AM
Period
Simple
Exponential
MA5
1.94Buy
1.96Buy
MA10
1.96Buy
1.92Buy
MA20
1.78Buy
1.98Buy
MA50
3.08Sell
2.80Sell
MA100
4.26Sell
3.69Sell
MA200
5.28Sell
4.29Sell
Syros Pharmaceuticals’s (SYRS) 10-Day exponential moving average is 1.92, while Syros Pharmaceuticals’s (SYRS) share price is $2, making it a Buy.
Syros Pharmaceuticals’s (SYRS) 100-Day exponential moving average is 3.69, while Syros Pharmaceuticals’s (SYRS) share price is $2, making it a Sell.
Syros Pharmaceuticals’s (SYRS) stock price is $2 and Syros Pharmaceuticals’s (SYRS) 50-day simple moving average is 3.08, creating a Sell signal.
Syros Pharmaceuticals’s (SYRS) stock price is $2 and Syros Pharmaceuticals’s (SYRS) 100-day simple moving average is 4.26, creating a Sell signal.
Syros Pharmaceuticals’s (SYRS) stock price is $2 and Syros Pharmaceuticals’s (SYRS) 200-day simple moving average is 5.28, creating a Sell signal.

Syros Pharmaceuticals (SYRS) Technical Indicators

Nov 10, 2024, 01:41 AM
Name
Value
Implied Action
RSI (14)
43.52
Neutral
STOCH (9,6)
49.92
Neutral
STOCHRSI (14)
75.71
Neutral
MACD (12,26)
-0.20
Sell
ADX (14)
29.21
Neutral
Williams %R
-18.57
Sell
CCI (14)
68.89
Neutral
ATR (14)
0.19
-
Ultimate Oscillator
56.86
Neutral
ROC
33.33
Buy
Syros Pharmaceuticals’s (SYRS) Relative Strength Index (RSI) is 43.52, creating a Neutral signal.
Syros Pharmaceuticals’s (SYRS) Trend Strength Indicator (ADX) is 29.21, creating a Neutral signal.
Syros Pharmaceuticals’s (SYRS) Commodity Channel Index (CCI) is 68.89, creating a Neutral signal.
Syros Pharmaceuticals’s (SYRS) Price Rate of Change (ROC) is 33.33, creating a Buy signal.

FAQ

Is SYRS a Buy, Hold, or Sell?
Based on SYRS’s technical indicators, SYRS is a Hold.
    What is SYRS’s RSI (14)?
    SYRS’s RSI (14) is 43.52, which suggests SYRS is a Neutral.
      What is SYRS’s MACD?
      SYRS’s MACD is -0.20, which suggests SYRS is a Sell.
        What is SYRS’s 5-day moving average?
        SYRS’s 5-day moving average is 1.94, which suggests SYRS is a Buy.
          What is SYRS’s 20-day moving average?
          SYRS 20-day moving average is 1.78, which suggests SYRS is a Buy.
            What is SYRS’s 50-day moving average?
            SYRS’s 50-day moving average is 3.08, which suggests SYRS is a Sell.
              What is SYRS’s 200-day moving average?
              SYRS’s 200-day moving average is 5.28, which suggests SYRS is a Sell.
                What is SYRS’s Williams % R (14)?
                SYRS’s Williams % R (14) is -18.57, which suggests SYRS is a Sell.
                  What is SYRS’s CCI (14)?
                  SYRS’s CCI (14) is 68.89, which suggests SYRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis